Australia markets close in 1 hour 5 minutes

Kintara Therapeutics, Inc. (KTRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1810-0.0190 (-9.50%)
At close: 04:00PM EDT
0.1899 +0.01 (+4.92%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.06M
Enterprise value 20.57M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.81
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.51

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-88.40%
S&P500 52-week change 3-7.20%
52-week high 31.5900
52-week low 30.1410
50-day moving average 30.2220
200-day moving average 30.4160

Share statistics

Avg vol (3-month) 33.77M
Avg vol (10-day) 37.01M
Shares outstanding 565.53M
Implied shares outstanding 6N/A
Float 859.91M
% held by insiders 17.76%
% held by institutions 15.73%
Shares short (14 July 2022) 4384.51k
Short ratio (14 July 2022) 40.09
Short % of float (14 July 2022) 40.59%
Short % of shares outstanding (14 July 2022) 40.59%
Shares short (prior month 14 June 2022) 4425.54k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 307 May 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 307 May 2019

Financial highlights

Fiscal year

Fiscal year ends 29 June 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-94.47%
Return on equity (ttm)-187.79%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -23.86M
Net income avi to common (ttm)-26.42M
Diluted EPS (ttm)-0.6430
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.84M
Total cash per share (mrq)0.14
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.12
Book value per share (mrq)-0.06

Cash flow statement

Operating cash flow (ttm)-20.09M
Levered free cash flow (ttm)-11.29M